CT
Christopher Turner
Pediatrics / Pediatric Hematology-Oncology
Credentials: ·
Research
A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias
New England Journal of Medicine · 2013 · 890 citations
Ponatinib in refractory Philadelphia chromosome-positive leukemias
New England Journal of Medicine · 2012 · 609 citations
The Lancet Oncology · 2021 · 362 citations
- MK
12 papers
10 papers
- LG
9 papers
- KM
8 papers
8 papers · 8 as a fellow
- CC
7 papers
- RS
5 papers
5 papers
